On March 21, the Guangdong-Macau medical-industry-academia-research Traditional Chinese Medicine (TCM) project for the prevention and treatment of major diseases was officially signed at Zhongshan Chen Xinghai Hospital of Integrated Traditional Chinese and Western Medicine (hereinafter referred to as "Chen Xinghai Hospital"). Promoted by the University of Macau's Macau Institute for Translational Medicine Innovation (hereinafter referred to as "Macau Translational Medicine Institute"), Chen Xinghai Hospital, Macau Jinchuangke Co., Ltd., and Guangdong-Macau Pharmaceuticals Co., Ltd. jointly signed a cooperation agreement. The three parties—universities, hospitals, and enterprises—plan to leverage the specialized service platform of Guangdong-Macau Pharmaceuticals' "TCM Preparation Center for Guangdong-Macau Medical Institutions" to develop new TCM preparations in medical institutions and promote the translational application of new TCM drugs in these preparations, thereby innovatively activating and cultivating new productive forces in the TCM industry.
It is reported that the first 'Eucommia Polysaccharide Wound Dressing,' independently developed by the University of Macau and collaboratively translated by the Macau Institute of Translational Medicine, Chen Xinghai Hospital, and Macau Jinchuangke Co., Ltd., is the main product of this cooperation project.
The 'Eucommia Polysaccharide Wound Dressing' is a new traditional Chinese medicine preparation that helps diabetic patients accelerate wound healing. As the first Grade III-A integrated traditional Chinese and Western medicine hospital jointly established by Guangdong and Hong Kong, Chen Xinghai Hospital not only incorporates Hong Kong's modern medical management system but is also among the first medical institutions in mainland China to implement the 'Hong Kong-Macau Drugs and Medical Devices Communication' policy. In recent years, through this policy, Chen Xinghai Hospital has introduced a variety of innovative drugs listed in Hong Kong and Macau, providing convenience for cross-border patients seeking medical treatment.
Currently, with changes in diet and lifestyle habits, the prevalence of diabetes is rising year by year. As a specialty hospital in Zhongshan City, the endocrinology department of Chen Xinghai Hospital sees a large number of diabetic patients every year. Most of these diabetic patients face difficulties in wound healing due to poor blood circulation. In order to provide more effective drug treatment for diabetic patients, Chen Xinghai Hospital is taking this project as an opportunity to participate in the translational implementation of the 'Eucommia Polysaccharide Wound Dressing'.
"Eight years ago, the University of Macau began researching 'Eucommia ulmoides polysaccharides,' aiming to transform it into a medical product that aids wound healing for diabetes patients. Currently, the project has progressed to the clinical trial stage. We hope that through the Guangdong-Macau medical-industry-academia-traditional Chinese medicine cooperation project, this traditional Chinese medicine formulation can be effectively applied and used in the Guangdong-Hong Kong-Macao Greater Bay Area," said Professor Wang Chunming of the University of Macau, the inventor of the technology.
Huang Hanwei, Party Secretary and President of Zhongshan Chen Xinghai Integrated Traditional Chinese and Western Medicine Hospital, introduced that the partner in this project, the Macau Institute of Translational Medicine and Innovation of the University of Macau, is a research institute led and managed by members of Academician Zhong Nanshan's team. To promote the transformation of medical and pharmaceutical scientific achievements in Macau, the institute has been exploring the establishment of a registration guidance system for innovative drugs in Macau, integrating scientific and technological innovations and talents in traditional Chinese medicine and translational medicine from both Macau and mainland China, and empowering the development of downstream industries.
“Macau Jinchuangke Co., Ltd. is a startup founded by the University of Macau and its research team, with the university holding shares. It is responsible for the commercialization and promotion of relevant technologies from the University of Macau, serving pharmaceutical, cosmetic, and health food manufacturing companies, as well as medical institutions worldwide,” said Huang Hanwei. Leveraging the Traditional Chinese Medicine pharmaceutical platform in the Hengqin Guangdong-Macao Deep Cooperation Zone — Guangdong-Macao Pharmaceutical Co., Ltd., multiple parties will jointly establish an innovative incubation platform for traditional Chinese medicine preparations for medical institutions across Guangdong and Macau, promoting the clinical translation of Macau's medical research achievements and their application within the Guangdong-Hong Kong-Macao Greater Bay Area.
As one of the key construction projects in the Guangdong-Hong Kong-Macao Greater Bay Area, the Zhongshan Municipal Government has positioned Chen Xinghai Hospital as a high-level flagship hospital for the integration of Chinese and Western medicine in Zhongshan. It is responsible for the inheritance and exchange of Chinese and Western medical culture connecting northern Zhongshan with Hong Kong and Macao. The signing of this project will strongly promote cooperation between Chinese medicine hospitals in Guangdong and Macao, and in the process of translating new Chinese medicine formulations into practical applications, it will cultivate and develop new quality productivity in the medical and pharmaceutical field.